Clinical trial
Treating Nonalcoholic Steatohepatitis (NASH) With Metformin
NCT00063232 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00063232 |
|---|---|
| Title | Treating Nonalcoholic Steatohepatitis (NASH) With Metformin |
| Official title | Treatment of Nonalcoholic Steatohepatitis With Metformin |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis |
| Intervention type | Drug |
| Interventions | Metformin |
| Enrollment | 28 |
| Start date | Jun 1, 2003 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Jun 24, 2003 |
| Last update posted | Jul 20, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: